{"id":"tp-56922","type":"article-newspaper","title":"Appili Therapeutics Posts C$3.5 Million First-Half Net Loss","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/56922","datePublished":"2026-11-13T17:35:32.000Z","dateModified":"2026-11-13T17:35:32.000Z","language":"en","abstract":"The loss widened C$1.3 million from a year earlier as the company shifted toward dual-use medical technologies and disclosed C$1.2 million in related-party advances.","section":"Business","references":[]}